Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia 33Breast Neoplasms 20Leukemia, Myeloid, Acute 15Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 13Head and Neck Neoplasms 13Congenital Abnormalities 12Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 9Kidney Neoplasms 9Central Nervous System Neoplasms 9Sarcoma 8Rectal Neoplasms 8Leukemia, Megakaryoblastic, Acute 8Colorectal Neoplasms 8Colonic Neoplasms 8Lymphoma, Follicular 7Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Erythroblastic, Acute 7Gliosarcoma 7Glioblastoma 7Multiple Myeloma 6Melanoma 6Neuroblastoma 5Lymphoma, Large B-Cell, Diffuse 5Esophageal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Wilms Tumor 4

Interventions

Paclitaxel 37Carboplatin 28pembrolizumab 19Surveys and Questionnaires 11temsirolimus 10Radiotherapy 10Cisplatin 10Doxorubicin 9Bevacizumab 9lenvatinib 8Docetaxel 8Nivolumab 7Metformin 7Gemcitabine 7Early Intervention, Educational 7Counseling 7Sirolimus 6Radiation 6Megestrol Acetate 6Indocyanine Green 6olaparib 5Topotecan 5Therapeutics 5Psychiatric Rehabilitation 5Methods 5Letrozole 5Ipilimumab 5Chemotherapy, Adjuvant 5ridaforolimus 4Trastuzumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endometrial Neoplasms × Gene Expression Profiling × Clear all
NCT00770185 2023-08-04

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Canadian Cancer Trials Group

Phase 2 Completed
35 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡